Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

label:1679 (Glytoucan)

Id:fca8b940-9e73-501e-91a3-bf487ed509f2

Glytoucan:G48213MO

Results found

Linked to

	Label	Description
	label:1679 has canonical residue n-glycan a-d-manp 21 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 has glycosequence GLYGEN.GLYCOSEQUENCE:G23869AA-GLYCOSEQ00060860 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 has glycosequence GLYGEN.GLYCOSEQUENCE:G23869AA-GLYCOSEQ00060859 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 has glycosequence GLYGEN.GLYCOSEQUENCE:G65059GX-GLYCOSEQ00117961 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	GLYCOSYLATION.SITE:SITE00014760 CUI has saccharide label:1679 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 has canonical residue n-glycan a-d-manp 21

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000026 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 has glycosequence GLYGEN.GLYCOSEQUENCE:G23869AA-GLYCOSEQ00060860 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 has glycosequence GLYGEN.GLYCOSEQUENCE:G23869AA-GLYCOSEQ00060859 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 has glycosequence GLYGEN.GLYCOSEQUENCE:G65059GX-GLYCOSEQ00117961 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000024 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000002 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

label:1679 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000023 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

GLYCOSYLATION.SITE:SITE00014760 CUI has saccharide label:1679

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.